Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression

References

• Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). J Clin Med. 2020;9:11. doi:10.3390/jcm9113426
   Web of Science ®Google Scholar
• Li LC, Han YY, Zhang ZH, et al. Chronic obstructive pulmonary disease treatment and pharmacist-led medication management. Drug Des Devel Ther. 2021;15:111–124. doi:10.2147/DDDT.S286315
   PubMed Web of Science ®Google Scholar
• Wu L, Chen Y, Yi J, et al. Mechanism of action of bu-fei-yi-shen formula in treating chronic obstructive pulmonary disease based on network pharmacology analysis and molecular docking validation. Biomed Res Int. 2020;2020:9105972. doi:10.1155/2020/9105972
   PubMed Web of Science ®Google Scholar
• Rutten EP, Gopal P, Wouters EF, et al. Various mechanistic pathways representing the aging process are altered in COPD. Chest. 2016;149(1):53–61. doi:10.1378/chest.15-0645
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med. 2019;200(5):556–564. doi:10.1164/rccm.201810-1975TR
   PubMed Web of Science ®Google Scholar
• Birch J, Anderson RK, Correia-Melo C, et al. DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015;309(10):L1124–37. doi:10.1152/ajplung.00293.2015
   PubMed Web of Science ®Google Scholar
• Li L, Wang Y, Gao W, et al. Klotho reduction in alveolar macrophages contributes to cigarette smoke extract-induced inflammation in chronic obstructive pulmonary disease. J Biol Chem. 2015;290(46):27890–27900. doi:10.1074/jbc.M115.655431
   PubMed Web of Science ®Google Scholar
• Kureya Y, Kanazawa H, Ijiri N, et al. Down-regulation of soluble alpha-klotho is associated with reduction in serum irisin levels in chronic obstructive pulmonary disease. Lung. 2016;194(3):345–351. doi:10.1007/s00408-016-9870-7
   PubMed Web of Science ®Google Scholar
• Gao W, Yuan C, Zhang J, et al. Klotho expression is reduced in COPD airway epithelial cells: effects on inflammation and oxidant injury. Clin Sci. 2015;129(12):1011–1023. doi:10.1042/CS20150273
   PubMed Web of Science ®Google Scholar
• Wang WM, Wu LC, Chen B, et al. Effects of Bufei Yishen formula on klotho gene expression and inflammation-related RIG-I/NF-κB pathway in cigarette smoke extract-treated BEAS-2B cells. Trop J Pharm Res. 2018;17(10):1925–1931. doi:10.4314/tjpr.v17i10.5
   Web of Science ®Google Scholar
• Blake DJ, Reese CM, Garcia M, et al. Soluble extracellular Klotho decreases sensitivity to cigarette smoke induced cell death in human lung epithelial cells. Toxicol In Vitro. 2015;29(7):1647–1652. doi:10.1016/j.tiv.2015.06.019
   PubMed Web of Science ®Google Scholar
• Dang X, He B, Ning Q, et al. Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-kappaB pathways. Respir Res. 2020;21(1):95. doi:10.1186/s12931-020-01358-4
   PubMed Web of Science ®Google Scholar
• Chen CH, Li YR, Lin SH, et al. Tiotropium/Olodaterol treatment reduces cigarette smoke extract-induced cell death in BEAS-2B bronchial epithelial cells. BMC Pharmacol Toxicol. 2020;21(1):74. doi:10.1186/s40360-020-00451-0
   PubMed Web of Science ®Google Scholar
• Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51. doi:10.1038/36285
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Nakamura M, Okubo K, et al. Isolation of a cDNA encoding a widely expressed novel zinc finger protein with the LeR and KRAB-A domains. Biochim Biophys Acta. 1997;1353(1):13–17. doi:10.1016/S0167-4781(97)00074-2
   PubMedGoogle Scholar
• Williams AJ, Blacklow SC, Collins T. The zinc finger-associated SCAN box is a conserved oligomerization domain. Mol Cell Biol. 1999;19(12):8526–8535. doi:10.1128/MCB.19.12.8526
   PubMed Web of Science ®Google Scholar
• Frietze S, Lan X, Jin VX, et al. Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem. 2010;285(2):1393–1403. doi:10.1074/jbc.M109.063032
   PubMed Web of Science ®Google Scholar
• Leng L, Sun J, Huang J, et al. Single-cell transcriptome analysis of uniparental embryos reveals parent-of-origin effects on human preimplantation development. Cell Stem Cell. 2019;25(5):697–712 e6. doi:10.1016/j.stem.2019.09.004
   PubMed Web of Science ®Google Scholar
• Afify AY. A miRNA’s insight into the regenerating heart: a concise descriptive analysis. Heart Fail Rev. 2020;25(6):1047–1061. doi:10.1007/s10741-019-09896-w
   PubMed Web of Science ®Google Scholar
• Khan R, Raza SHA, Junjvlieke Z, et al. Function and transcriptional regulation of bovine TORC2 gene in adipocytes: roles of C/EBP, XBP1, INSM1 and ZNF263. Int J Mol Sci. 2019;20:18. doi:10.3390/ijms20184338
   Web of Science ®Google Scholar
• Zhao P, Li J, Yang L, et al. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease. Mol Med Rep. 2018;17(4):5247–5257. doi:10.3892/mmr.2018.8480
   PubMed Web of Science ®Google Scholar
• Zhao P, Liu X, Dong H, et al. Bufei yishen formula restores Th17/treg balance and attenuates chronic obstructive pulmonary disease via activation of the adenosine 2a receptor. Front Pharmacol. 2020;11:1212. doi:10.3389/fphar.2020.01212
   PubMed Web of Science ®Google Scholar
• Guan Q, Zhao P, Tian Y, et al. Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes. Ann Med. 2022;54(1):2309–2320. doi:10.1080/07853890.2022.2112070
   PubMed Web of Science ®Google Scholar
• Li J, Yang L, Yao Q, et al. Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model. Evid Based Complement Alternat Med. 2014;2014:381976. doi:10.1155/2014/381976
   PubMed Web of Science ®Google Scholar
• Jin F, Zhang L, Chen K, et al. Effective-component compatibility of bufei yishen formula III combined with electroacupuncture suppresses inflammatory response in rats with chronic obstructive pulmonary disease via regulating SIRT1/NF-kappaB signaling. Biomed Res Int. 2022;2022:3360771. doi:10.1155/2022/3360771
   PubMed Web of Science ®Google Scholar
• Li J, Zhao P, Yang L, et al. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling. Sci Rep. 2016;6:25492. doi:10.1038/srep25492
   PubMed Web of Science ®Google Scholar